Results 141 to 150 of about 8,627 (176)
Journal of Clinical Pharmacology, 2005 Dabigatran etexilate is an oral low-molecular-weight direct thrombin inhibitor. Following oral administration, dabigatran etexilate is rapidly converted to its active form, dabigatran.
Gerhard Nehmiz
exaly +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 2008
Dabigatran etexilate is an orally administered prodrug of dabigatran, which is a potent, concentration-dependent inhibitor of thrombus formation and thrombin-induced platelet aggregation. Dabigatran etexilate pharmacokinetics were linear across a wide dosage range.
Mark, Sanford, Greg L, Plosker
openaire +2 more sources
Dabigatran etexilate is an orally administered prodrug of dabigatran, which is a potent, concentration-dependent inhibitor of thrombus formation and thrombin-induced platelet aggregation. Dabigatran etexilate pharmacokinetics were linear across a wide dosage range.
Mark, Sanford, Greg L, Plosker
openaire +2 more sources
Dabigatran/Dabigatran etexilate
Drugs of the Future, 2005null Sorbera, L.A. +2 more
openaire +1 more source